> Detailanzeige

Schleicher, Sabine Barbara [VerfasserIn]; Grote, Stefan [VerfasserIn]; Malenke, Elke [VerfasserIn]; Chan, Kenneth Chun-Ho [VerfasserIn]; Schaller, Martin [VerfasserIn]; Fehrenbacher, Birgit [VerfasserIn]; Riester, Rosa [VerfasserIn]; Kluba, Torsten [VerfasserIn]; Frauenfeld, Leonie [VerfasserIn]; Bösmüller, Hans [VerfasserIn]; Göhring, Gudrun [VerfasserIn]; Schlegelberger, Brigitte [VerfasserIn]; Handgretinger, Rupert [VerfasserIn]; Kopp, Hans-Georg [VerfasserIn]; Traub, Frank [VerfasserIn]; Böhme, Karen Andrea [VerfasserIn]

Establishment and characterization of a sclerosing spindle cell rhabdomyosarcoma cell line with a complex genomic profile

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Book; Sonderdruck
  • Titel: Establishment and characterization of a sclerosing spindle cell rhabdomyosarcoma cell line with a complex genomic profile
  • Beteiligte: Schleicher, Sabine Barbara [VerfasserIn]; Grote, Stefan [VerfasserIn]; Malenke, Elke [VerfasserIn]; Chan, Kenneth Chun-Ho [VerfasserIn]; Schaller, Martin [VerfasserIn]; Fehrenbacher, Birgit [VerfasserIn]; Riester, Rosa [VerfasserIn]; Kluba, Torsten [VerfasserIn]; Frauenfeld, Leonie [VerfasserIn]; Bösmüller, Hans [VerfasserIn]; Göhring, Gudrun [VerfasserIn]; Schlegelberger, Brigitte [VerfasserIn]; Handgretinger, Rupert [VerfasserIn]; Kopp, Hans-Georg [VerfasserIn]; Traub, Frank [VerfasserIn]; Böhme, Karen Andrea [VerfasserIn]
  • Erschienen: Basel: MDPI AG, 2020
  • Erschienen in: Cells ; 9, 12 (2020), 2668
  • Umfang: 1 Online-Ressource (26 Seiten); Illustrationen, Diagramme; Supplementary material (1 ZIP-Datei: 1 .docx-Datei, 1 .xlsx-Datei)
  • Sprache: Englisch
  • DOI: 10.3390/cells9122668
  • ISSN: 2073-4409
  • Identifikator:
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Abstract: Sclerosing spindle cell rhabdomyosarcoma (SSRMS) is a rare rhabdomyosarcomas (RMS) subtype. Especially cases bearing a myogenic differentiation 1 (MYOD1) mutation are characterized by a high recurrence and metastasis rate, often leading to a fatal outcome. SSRMS cell lines are valuable in vitro models for studying disease mechanisms and for the preclinical evaluation of new therapeutic approaches. In this study, a cell line established from a primary SSRMS tumor of a 24-year-old female after multimodal chemotherapeutic pretreatment has been characterized in detail, including immunohistochemistry, growth characteristics, cytogenetic analysis, mutation analysis, evaluation of stem cell marker expression, differentiation potential, and tumorigenicity in mice. The cell line which was designated SRH exhibited a complex genomic profile, including several translocations and deletions. Array-comparative genomic hybridization (CGH) revealed an overall predominating loss of gene loci. The mesenchymal tumor origin was underlined by the expression of mesenchymal markers and potential to undergo adipogenic and osteogenic differentiation. Despite myogenic marker expression, terminal myogenic differentiation was inhibited, which might be elicited by the MYOD1 hotspot mutation. In vivo tumorigenicity could be confirmed after subcutaneous injection into NOD/SCID/γcnull mice. Summarized, the SRH cell line is the first adult SSRMS cell line available for preclinical research on this rare RMS subtype
  • Zugangsstatus: Freier Zugang